A Phase I, Open-Label, Crossover, Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus in Healthy Volunteers

Trial Profile

A Phase I, Open-Label, Crossover, Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Mar 2018

At a glance

  • Drugs Apixaban (Primary) ; Ciclosporin (Primary) ; Tacrolimus (Primary)
  • Indications Venous thromboembolism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Mar 2018 Results investigating drug interaction between Cyclosporine and Tacrolimus with Apixaban presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 10 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 19 May 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top